FDA inspection
Samyang Biopharmaceuticals Corporation: FDA inspection ending Aug 30, 2019
FDA inspection 1102618 · Daedeok
Key facts
| Inspection ID | 1102618 |
|---|---|
| Firm | Samyang Biopharmaceuticals Corporation |
| FEI number | 3009291004 |
| Address | Daedeok, 79 Sinildong-Ro |
| City | Daedeok |
| Fiscal year | 2019 |
| Inspection end date | Aug 30, 2019 |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data